Submitted by Anonymous (not verified) on 4 December 2023 - 16:41
Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Leiomyoma, Date of authorisation: 16/07/2021, Revision: 6, Status: Authorised
Source: